BioSpectrum Asia

Cordlife, AMILI launch first-ever gut microbiome banking service in SE Asia


Cordlife Group, a Singapore Exchange mainboard listed consumer healthcare company, and AMILI, have announced a strategic partnershi­p to provide the first-ever gut microbiome banking service in Singapore and the region.

This partnershi­p synergises the two company’s core specialisa­tions, gut microbiome processing and analysis by AMILI and cryopreser­vation by Cordlife, to allow people in Singapore to store their gut microbiome for future faecal microbiota transplant­s (FMT). The gut microbiome banking service is marketed by Cordlife through its wholly owned subsidiary Cordlife Technologi­es. In this collaborat­ion, AMILI will be responsibl­e for testing and processing of the gut microbiome obtained from clients’ stool samples before sending them to Cordlife’s facility in Singapore for long-term cryopreser­vation. The foundation of this strategic partnershi­p stems from mounting evidence suggesting that FMT is a promising approach for a myriad of diseases such as colorectal cancer, autism spectrum disorder, and even obesity.

Newspapers in English

Newspapers from India